Top Tweets for #Brca
BRCA testing in real-world prostate cancer
Precision oncology depends on reliable molecular testing
This Italian multicentre study explores the successes and practical challenges of BRCA testing in metastatic castration-resistant prostate cancer
#BRCA #ProstateCancer #Pathologica
Beyond the Gates July 16: BRCA Bombshell, Tense Dinner, and Marriage Reflections
More details: https://t.co/LXHK9fui2E
#BeyondTheGates #BTG #Soaps #DaytimeDrama #BeyondTheGatesSpoilers #Naomi #BRCA #CTS #SoapOpera #FairmontCrest
Thursday's episode of Beyond the Gates promise…
🧬 Cada vez sabemos más y podemos decidir mejor 📡 #RADARGEICAM reunió a especialistas de referencia para revisar los últimos avances que están transformando la práctica clínica. Entre ellos, el papel del test germinal #BRCA, que está impulsando decisiones más personalizadas en prevención, tratamiento y seguimiento del #CáncerDeMamaHereditario ⬇️
📣#LoMásLeído| 🔬 #Oncología | Radar @GEICAM reunió a más de 300 especialistas para actualizar, desde una perspectiva multidisciplinar, los avances en diagnóstico, tratamiento, seguimiento y calidad de vida en cáncer de mama
@matteolambe #Investigación
https://t.co/167BZXYF3R
Beyond The Gates: Leslie and Darlene Forge Unlikely Truce Over Soup Recipe
More details: https://t.co/xHpmVxN4Vy
#BeyondTheGates #BeyondTheGatesRecap #Soapopera #Daytime #DaytimeDrama #TeamNaomi #BRCA #TheImpaler #SoapTwitter #BeyondTheGatesSpoilers
Soap opera Beyond The Gat…
🇺🇸 ABD Senatörü Ron Wyden, blok zinciri yazılım geliştiricilerine hukuki koruma sağlayan BRCA düzenlemesinin Clarity Act kapsamındaki nihai yasa paketinde yer alması çağrısında bulundu.
#ClarityAct #Kripto #BRCA #blockchain
https://t.co/MrwnFL0BtD
Article✍️#RAD51-targeting small #molecule #degrader sensitizes #BRCA-#proficient prostate #cancer cells to #PARP #inhibitors via #synthetic #lethality. From Dr. Li @Xi'anJiaotongUniversity; @Sciencedirect; @ElsevierConnect.
https://t.co/LvUD21ohxg.
Timing is everything - check out this @ASCO Daily News podcast which features @matteolambe discussing the timing of #BRCA testing in patients with #breastcancer!
🎙 @montypal of @cityofhope and @matteolambe of @UniGenova discuss the importance of identifying BRCA 1/2 status in healthy people and how early breast cancer detection could lead to better prognosis on the #ASCODailyNews Podcast: https://t.co/IfoDbwgwbl
Congratulations to Dipanjan Chowdhury @ChowdhuryLab and the team on this award! Thank you to Mindy and Jon Gray and the Gray Foundation for supporting BRCA-related cancer research. #BRCA #CancerResearch #TranslationalResearch #GrayFoundation
So thankful to Mindy and Jon Gray of the Gray Foundation for the award to our lab for BRCA-Related Cancer Research!
And a thank you to @WojciechFendler from the Medical University of Lodz.
https://t.co/soi4Vi7U5V
Check out NERINE, network-based framework for rare-variant association, now published in @CellGenomics. We reveal potential disease gene modules in several complex diseases, including Parkinson's.
#rarevariantassoc #Parkinsons #CAD #T2D #BRCA
NERINE reveals rare variant associations in gene networks across phenotypes and implicates an SNCA-PRL-LRRK2 subnetwork in Parkinson’s disease https://t.co/Muc7baGIO9
My mom had breast cancer at 39 and 49. I turn 52 on Monday.
We were both BRCA negative.
Despite not carrying the gene, my risk was 80%.
Prophylactic double mastectomy in Feb. Reconstruction yesterday.
From 80% to 4%. 🍑
#BRCA #BreastCancer
🚨 The @US_FDA has approved datopotamab deruxtecan (Dato-DXd) for patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not candidates for immunotherapy.
The approval was based on results from the international Tropion-Breast02 clinical trial, led in the U.S. by MSK breast medical oncologist Dr. Tiffany Traina. Learn more: https://t.co/LWY0SMzD9n
#EditorsChoice 🧬 Personalizing #OvarianCancer prevention in women with #BRCA pathogenic variants
🔍 https://t.co/9XQh47jo7n
@pedroramirezMD @RParejaGineOnco @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @ElePanizzolo @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde
What if primary care became the front line of hereditary cancer prevention?
A new #JGIM #Editorial argues that ⬆️ #BRCA testing in primary care could help identify millions of high-risk women & prevent breast/ovarian cancers
🆓 full-text ⬇️:
https://t.co/TcWFp73ECl
Congratulations to Carman Man-Chung Li, PhD, 2026 Young Investigator Award recipient from the @basserbrca Young Leadership Council! Dr. Li studies the earliest stages of BRCA1-related breast cancer to advance cancer interception. #BRCA #cancerresearch @penncancer
Ahead of #ASCO26, I selected some less high-profile but, in my opinion, really interesting breast cancer abstracts focused on #YoungPatients and #BRCA carriers (plus the 2 abstracts our group will present on these topics).
@matteolambe @E_de_Azambuja @OncoAlert @ASCO
#ClarityAct = 🤡🌎
To onboard some democrats for the final vote at the Senate, they literally prioritize stablecoins yield over civil liberties.
KEEP #BRCA (devs protection) or KILL THE BILL
Received intel from the CLARITY Act hearing today: "Dems are coming for BRCA, specifically protections for devs."
"Republicans are willing to remove developer protections to get some Democrats on board. Without developer protections we get absolutely nothing from this bill. Kill the bill. No bill is better than a bad bill."
It's #ThrowbackThursday.
A book of the heart. Breast cancer is hitting women at younger ages. My survivor story is in the back of "Christmas at Whispering Creek."
#breastcancer #BRCA #Christfic #Romance
https://t.co/yTCutB5ddV
Nel carcinoma mammario oggi non basta colpire il bersaglio. Bisogna farlo nel momento giusto.
#BRCA, pathway #AKT, profilazione molecolare: la medicina di precisione ha cambiato le regole del gioco. Ma la vera sfida resta trasformare l’innovazione in pratica clinica quotidiana, garantendo decisioni tempestive, condivise e realmente multidisciplinari.
A Cinisello Balsamo si sta svolgendo la nuova tappa di ON TARGET IN TIME, il percorso itinerante macroregionale che attraversa l’Italia per costruire una visione comune della #MedicinadiPrecisione nel carcinoma mammario.
Tavole rotonde e attività interattive rappresentano il cuore del confronto: oncologi, chirurghi e anatomo-patologi insieme su casi clinici reali, tra evidenze scientifiche, esperienza e tempi decisionali da rispettare.
Accanto alla scelta terapeutica, un focus fondamentale sulla comunicazione con la paziente: come e quando condividere percorsi, opzioni e decisioni, perché precisione significa anche integrazione, ascolto e qualità del dialogo.
ON TARGET IN TIME continua il suo percorso sul territorio con un obiettivo chiaro: trasformare la complessità in azioni concrete, rapide e coordinate, perché ogni mutazione può rappresentare un’opportunità e ogni timing può fare la differenza.
Responsabili Scientifici: Carmen Criscitiello, Matteo Lambertini, Claudio Vernieri. @CarmenCriscit
@matteolambe
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.7M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.2M followers
Taylor Swift
@taylorswift13
82.1M followers
Lady Gaga
@ladygaga
73.6M followers
Virat Kohli
@imvkohli
70.8M followers
Kim Kardashian
@kimkardashian
70.1M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.7M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.3M followers
X
@x
60.8M followers